AMANDA O'MALLEY: Open Payments
NPI 1356013171 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,370 in 116 payments from 17 companies in 2025. Trend: 2023 $439 · 2024 $1,306 · 2025 $2,370
Food & beverage: $2,094Education: $276
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $630 |
| Novartis Pharmaceuticals Corporation | 22 | $423 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $348 |
| Regeneron Healthcare Solutions, Inc. | 5 | $208 |
| Lilly USA, LLC | 9 | $144 |
| Janssen Biotech, Inc. | 4 | $110 |
| UCB, Inc. | 3 | $103 |
| GENZYME CORPORATION | 4 | $103 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Arcutis Biotherapeutics, Inc. | 3 | $53 |
Products named: SKYRIZI, COSENTYX, DUPIXENT, TALTZ, ILUMYA, TREMFYA, Bimzelx, Sotyktu.
Industry payments across NY — which companies pay providers there.
